about
Osteoprotegerin and RANKL in the pathogenesis of thalassemia-induced osteoporosis: new pieces of the puzzle.Genistein Supplementation and Cardiac Function in Postmenopausal Women with Metabolic Syndrome: Results from a Pilot Strain-Echo StudySkin Involvement and Pulmonary Hypertension Are Associated with Vitamin D Insufficiency in Scleroderma.Antiosteoporotic Activity of Genistein Aglycone in Postmenopausal Women: Evidence from a Post-Hoc Analysis of a Multicenter Randomized Controlled Trial.Effects of infliximab on sister chromatid exchanges and chromosomal aberration in patients with rheumatoid arthritisGenistein effects on quantitative ultrasound parameters and bone mineral density in osteopenic postmenopausal women.Higher serum sclerostin levels and insufficiency of vitamin D are strongly associated with vertebral fractures in hemodialysis patients: a case control study.Denosumab Inhibition of RANKL and Insulin Resistance in Postmenopausal Women with Osteoporosis.The clinical and rehabilitative complexity in dementia with Lewy bodies (DLB): experience on a random sample of elderly patients dwelling in an RSA ("Residenza Sanitaria Assistita") of Catania.Genistein effects on quality of life and depression symptoms in osteopenic postmenopausal women: a 2-year randomized, double-blind, controlled study.Efficacy of genistein aglycone on some cardiovascular risk factors and homocysteine levels: A follow-up study.Bone mineral density, quantitative ultrasound parameters and bone metabolism in postmenopausal women with depression.Breast safety and efficacy of genistein aglycone for postmenopausal bone loss: a follow-up study.Effects of phytoestrogen genistein on cytogenetic biomarkers in postmenopausal women: 1 year randomized, placebo-controlled study.Osteoprotegerin and bone mineral density in hemodiafiltration patients.The ESR2 AluI 1730G>A (rs4986938) gene polymorphism is associated with fibrinogen plasma levels in postmenopausal women.Vitamin D Status and the Relationship with Bone Fragility Fractures in HIV-Infected Patients: A Case Control Study.Effects of the phytoestrogen genistein on some predictors of cardiovascular risk in osteopenic, postmenopausal women: a two-year randomized, double-blind, placebo-controlled study.The ESR2 AluI gene polymorphism is associated with bone mineral density in postmenopausal women.Visfatin correlates with hot flashes in postmenopausal women with metabolic syndrome: effects of genistein.Effects of strontium ranelate on markers of cardiovascular risk in postmenopausal osteoporotic women.Bone health assessment by quantitative ultrasound and dual-energy x-ray absorptiometry in postmenopausal women with breast cancer receiving aromatase inhibitors.Correction: Propylthiouracil prevents cutaneous and pulmonary fibrosis in the reactive oxygen species murine model of systemic sclerosis.Adrenal effects of teriparatide in the treatment of severe postmenopausal osteoporosis
P50
Q33339910-D955F4B5-56F9-4BBF-A1E0-027B99F5B805Q33851976-B05FF4A0-84D8-42C6-BD11-BF742E1B6172Q37534843-0416AC45-E647-4615-A3CC-1DF337B0D814Q37673312-EC7B0429-BF2D-4C53-B584-AD5BE8192140Q38459406-53C6AA21-B0B7-4869-8350-066A59A314E1Q38496372-91124229-47C0-4B34-860B-2C6AD2F341E2Q39342144-DAD5420F-B1CA-40AB-9223-520903F91943Q41189137-A296464F-13E8-4110-84A6-F35F35E62454Q43308293-4F1B7421-9088-4005-86DD-7E582E6D5CD6Q45897175-D1A19E21-68CE-4572-9806-7B79B20893CEQ45920332-C9890F98-C3AC-41A4-816F-8EC6717A2515Q45980823-AF675EF8-AECD-44D1-B4B4-C326D4744E33Q46363722-070228F6-3AF1-4EEF-B804-6761815082DCQ46549826-F7678150-85A5-4B7C-9156-1DC613973991Q46694718-DF1BF8B1-3189-4298-A245-2A5AAF462F87Q47243182-6A54C317-0352-41DA-9501-43262B1FBCC3Q48308691-E24F25F9-9B7D-4C78-A281-6DDC338B1A5FQ50776408-A6101BD7-0810-4558-B586-97D45732C982Q50789087-46851804-C6FA-4C7E-94AC-D82AC92C9556Q50858035-60169234-C664-4893-BC94-133B5D9426F4Q51298130-32CF73C8-F712-4876-AEF1-DF441F19B3E4Q51831921-99E52E53-1E7C-413E-BE8F-342EA916A8EEQ55609982-2DE9C8AF-247F-40DB-9F66-F46F02278AFEQ83824713-655E9E46-D181-46F7-8763-C11A502AE2EB
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Marco Atteritano
@ast
Marco Atteritano
@en
Marco Atteritano
@es
Marco Atteritano
@nl
Marco Atteritano
@sl
type
label
Marco Atteritano
@ast
Marco Atteritano
@en
Marco Atteritano
@es
Marco Atteritano
@nl
Marco Atteritano
@sl
prefLabel
Marco Atteritano
@ast
Marco Atteritano
@en
Marco Atteritano
@es
Marco Atteritano
@nl
Marco Atteritano
@sl
P106
P1153
8718290100
P21
P31
P496
0000-0001-9342-802X